{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:53:06Z","timestamp":1787849586775,"version":"build-2784847793"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00210-023-02873-z","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T09:02:38Z","timestamp":1702285358000},"page":"3675-3693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gene therapy: an alternative to treat Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"397","author":[{"given":"Vanshika","family":"Doshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"2873_CR1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.017","volume-title":"In: Human Gene Therapy (Vol. 27, Issue 2, pp. 100\u2013107)","author":"S Alves","year":"2016","unstructured":"Alves S, Fol R, Cartier N (2016) Gene therapy strategies for Alzheimer\u2019s disease: an overview. In: In: Human Gene Therapy (Vol. 27, Issue 2, pp. 100\u2013107). Mary Ann Liebert Inc. https:\/\/doi.org\/10.1089\/hum.2016.017"},{"key":"2873_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06512-9","volume-title":"Molecular Biology Reports (Vol. 48, Issue 7, pp. 5629\u20135645)","author":"T Athar","year":"2021","unstructured":"Athar T, al Balushi K, Khan SA (2021) Recent advances on drug development and emerging therapeutic agents for Alzheimer\u2019s disease. In: Molecular Biology Reports (Vol. 48, Issue 7, pp. 5629\u20135645). Springer Science and Business Media B.V. https:\/\/doi.org\/10.1007\/s11033-021-06512-9"},{"key":"2873_CR3","doi-asserted-by":"publisher","unstructured":"Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C (n.d.). Early-onset Alzheimer\u2019s disease: what is missing in research? https:\/\/doi.org\/10.1007\/s11910-020-01090-y\/Published","DOI":"10.1007\/s11910-020-01090-y\/Published"},{"issue":"2","key":"2873_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","volume":"21","author":"T Ayodele","year":"2021","unstructured":"Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C (2021) Early-onset Alzheimer\u2019s disease: what is missing in research? Curr Neuro Neurosci Rep 21(2):4. https:\/\/doi.org\/10.1007\/s11910-020-01090-y","journal-title":"Curr Neuro Neurosci Rep"},{"key":"2873_CR5","doi-asserted-by":"crossref","unstructured":"Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, Pappolla MA, Sambamurti K, Alzheimer C, Author R (2015). Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease HHS Public Access Author manuscript. In Curr Alzheimer Res (Vol. 12, Issue 1).","DOI":"10.2174\/1567205012666141218140953"},{"key":"2873_CR6","doi-asserted-by":"publisher","unstructured":"Baum C, D\u00fcllmann J, Li Z, Fehse B, Meyer J, Williams DA, von Kalle C (2003). Side effects of retroviral gene transfer into hematopoietic stem cells. In Blood (Vol. 101, Issue 6, pp. 2099\u20132114). https:\/\/doi.org\/10.1182\/blood-2002-07-2314","DOI":"10.1182\/blood-2002-07-2314"},{"key":"2873_CR7","doi-asserted-by":"publisher","unstructured":"Belloy ME, Napolioni V, Greicius MD (2019). A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward. In: Neuron (Vol. 101, Issue 5, pp. 820\u2013838). Cell Press. https:\/\/doi.org\/10.1016\/j.neuron.2019.01.056","DOI":"10.1016\/j.neuron.2019.01.056"},{"key":"2873_CR8","doi-asserted-by":"publisher","DOI":"10.1017\/S135561771700100X","volume-title":"Journal of the International Neuropsychological Society (Vol. 23, Issues 9-10 Special Issue, pp. 818\u2013831)","author":"MW Bondi","year":"2017","unstructured":"Bondi MW, Edmonds EC, Salmon DP (2017) Alzheimer\u2019s disease: past, present, and future. In: Journal of the International Neuropsychological Society (Vol. 23, Issues 9-10 Special Issue, pp. 818\u2013831). Cambridge University Press. https:\/\/doi.org\/10.1017\/S135561771700100X"},{"key":"2873_CR9","doi-asserted-by":"crossref","unstructured":"Briggs R, Kennelly SP, O'Neill D (2016) Drug treatments in Alzheimer\u2019s disease. Clinical medicine 16(3):247","DOI":"10.7861\/clinmedicine.16-3-247"},{"key":"2873_CR10","doi-asserted-by":"publisher","unstructured":"Bulaklak K, Gersbach CA (2020). The once and future gene therapy. In: Nature Communications (Vol. 11, Issue 1). Nature Research. https:\/\/doi.org\/10.1038\/s41467-020-19505-2","DOI":"10.1038\/s41467-020-19505-2"},{"key":"2873_CR11","doi-asserted-by":"publisher","unstructured":"Burrell M, Henderson SJ, Ravnefjord A, Schweikart F, Fowler SB, Witt S, Hansson KM, Webster CI (2016) Neprilysin inhibits coagulation through proteolytic inactivation of fibrinogen. PLoS ONE 11(7). https:\/\/doi.org\/10.1371\/journal.pone.0158114","DOI":"10.1371\/journal.pone.0158114"},{"key":"2873_CR12","doi-asserted-by":"publisher","unstructured":"Butt, M. H., Zaman, M., Ahmad, A., Khan, R., Mallhi, T. H., Hasan, M. M., Khan, Y. H., Hafeez, S., Massoud, E. E. S., Rahman, M. H., & Cavalu, S. (2022). Appraisal for the potential of viral and nonviral vectors in gene therapy: a review. In: Genes (Vol. 13, Issue 8). MDPI. https:\/\/doi.org\/10.3390\/genes13081370","DOI":"10.3390\/genes13081370"},{"key":"2873_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104847","volume-title":"Neurobiology of Disease","author":"DA Butterfield","year":"2020","unstructured":"Butterfield DA, Johnson LA (2020) APOE in Alzheimer\u2019s disease and neurodegeneration. In: Neurobiology of Disease, vol 139. Academic Press Inc. https:\/\/doi.org\/10.1016\/j.nbd.2020.104847"},{"issue":"7\u20138","key":"2873_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/hum.2019.367","volume":"31","author":"MJ Castle","year":"2020","unstructured":"Castle MJ, Baltan\u00e1s FC, Kovacs I, Nagahara AH, Barba D, Tuszynski MH (2020) Postmortem analysis in a clinical trial of AAV2-NGF gene therapy for Alzheimer\u2019s disease identifies a need for improved vector delivery. Human Gene Therapy 31(7\u20138):415\u2013422. https:\/\/doi.org\/10.1089\/hum.2019.367","journal-title":"Human Gene Therapy"},{"issue":"6","key":"2873_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1208\/s12249-023-02629-1","volume":"24","author":"K Chatterjee","year":"2023","unstructured":"Chatterjee K, Lakdawala S, Quadir SS, Puri D, Mishra DK, Joshi G, Sharma S, Choudhary D (2023) siRNA-based novel therapeutic strategies to improve effectiveness of antivirals: an insight. AAPS PharmSciTech 24(6):170. https:\/\/doi.org\/10.1208\/s12249-023-02629-1","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"2873_CR16","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","volume":"10","author":"W Chen","year":"2020","unstructured":"Chen W, Hu Y, Ju D (2020a) Gene therapy for neurodegenerative disorders: advances, insights and prospects. Acta Pharmaceutica Sinica B 10(8):1347\u20131359. https:\/\/doi.org\/10.1016\/j.apsb.2020.01.015","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2873_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.01.015","volume-title":"Acta Pharmaceutica Sinica B (Vol. 10, Issue 8, pp. 1347\u20131359)","author":"W Chen","year":"2020","unstructured":"Chen W, Hu Y, Ju D (2020b) Gene therapy for neurodegenerative disorders: advances, insights and prospects. In: Acta Pharmaceutica Sinica B (Vol. 10, Issue 8, pp. 1347\u20131359). Chinese Academy of Medical Sciences. https:\/\/doi.org\/10.1016\/j.apsb.2020.01.015"},{"key":"2873_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.10.008","volume-title":"Neuron (Vol. 109, Issue 2, pp. 205\u2013221)","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM (2021) Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. In: Neuron (Vol. 109, Issue 2, pp. 205\u2013221). Cell Press. https:\/\/doi.org\/10.1016\/j.neuron.2020.10.008"},{"issue":"1","key":"2873_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5607\/en.2014.23.1.45","volume":"23","author":"SS Choi","year":"2014","unstructured":"Choi SS, Lee S-R, Kim SU, Lee HJ (2014) Alzheimer\u2019s disease and stem cell therapy. Experimental Neurobiology 23(1):45\u201352. https:\/\/doi.org\/10.5607\/en.2014.23.1.45","journal-title":"Experimental Neurobiology"},{"key":"2873_CR20","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.15.188","volume-title":"Nanomedicine (Vol. 11, Issue 1, pp. 81\u2013100)","author":"C Corbo","year":"2016","unstructured":"Corbo C, Molinaro R, Parodi A, Toledano Furman NE, Salvatore F, Tasciotti E (2016) The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. In: Nanomedicine (Vol. 11, Issue 1, pp. 81\u2013100). Future Medicine Ltd. https:\/\/doi.org\/10.2217\/nnm.15.188"},{"key":"2873_CR21","doi-asserted-by":"publisher","unstructured":"Dziakov\u00e1 A, Valen\u010d\u00e1kov\u00e1 A, Hatalov\u00e1 E, Kalinov\u00e1 J (2016) The use of viral vectors in gene transfer therapy. Int J Pharmaceut Sci Drug Res 8(03). https:\/\/doi.org\/10.25004\/ijpsdr.2016.080301","DOI":"10.25004\/ijpsdr.2016.080301"},{"key":"2873_CR22","doi-asserted-by":"publisher","unstructured":"Ertl HCJ (2022) Immunogenicity and toxicity of AAV gene therapy. In: Frontiers in Immunology (Vol. 13), Frontiers Media S.A. https:\/\/doi.org\/10.3389\/fimmu.2022.975803","DOI":"10.3389\/fimmu.2022.975803"},{"key":"2873_CR23","doi-asserted-by":"publisher","unstructured":"Fahnestock M, Shekari A (2019) ProNGF and neurodegeneration in Alzheimer\u2019s disease. Front Neurosci 13:129.\u00a0https:\/\/doi.org\/10.3389\/fnins.2019.00129","DOI":"10.3389\/fnins.2019.00129"},{"key":"2873_CR24","doi-asserted-by":"publisher","unstructured":"Fattah S, Rehn M, Reierth E, Wisborg T\u00a0(2013) Systematic literature review of templates for reporting prehospital major incident medical management BMJ Open 3(8):e002658. https:\/\/doi.org\/10.1136\/bmjopen-2013-002658","DOI":"10.1136\/bmjopen-2013-002658"},{"key":"2873_CR25","unstructured":"Gardl\u00edk R, P\u00e1lffy R, Hodosy J, Luk\u00e1cs J, Turna J, Celec P (2005) Vectors and delivery systems in gene therapy. Med Sci Monit 11(4):110\u2013121"},{"key":"2873_CR26","doi-asserted-by":"publisher","unstructured":"Gauthier S, Leuzy A, Racine E, Rosa-Neto P (2013). Diagnosis and management of Alzheimer\u2019s disease: past, present and future ethical issues. In Progress in Neurobiology (Vol. 110, pp. 102\u2013113). https:\/\/doi.org\/10.1016\/j.pneurobio.2013.01.003","DOI":"10.1016\/j.pneurobio.2013.01.003"},{"key":"2873_CR27","unstructured":"Gene Therapy and Cell Transplantation. (n.d.)."},{"key":"2873_CR28","unstructured":"Gene Therapy as an Alternative. (n.d.)."},{"key":"2873_CR29","doi-asserted-by":"publisher","unstructured":"Giulimondi F, Digiacomo L, Pozzi D, Palchetti S, Vulpis E, Capriotti AL, Chiozzi RZ, Lagan\u00e0 A, Amenitsch H, Masuelli L, Mahmoudi M, Screpanti I, Zingoni A, Caracciolo G (2019) Interplay of protein corona and immune cells controls blood residency of liposomes. Nature. Communications 10(1). https:\/\/doi.org\/10.1038\/s41467-019-11642-7","DOI":"10.1038\/s41467-019-11642-7"},{"key":"2873_CR30","doi-asserted-by":"publisher","unstructured":"Gon\u00e7alves GAR, Paiva RDMA (2017) Gene therapy: advances, challenges and perspectives. Einstein (Sao Paulo) 15(3):369\u2013375.\u00a0https:\/\/doi.org\/10.1590\/S1679-45082017RB4024","DOI":"10.1590\/S1679-45082017RB4024"},{"issue":"23","key":"2873_CR31","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1001\/jama.2009.1866","volume":"302","author":"RC Green","year":"2009","unstructured":"Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH (2009) Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA 302(23):2557\u20132564. https:\/\/doi.org\/10.1001\/jama.2009.1866","journal-title":"JAMA"},{"key":"2873_CR32","doi-asserted-by":"publisher","unstructured":"Grimm MOW, Mett J, Stahlmann CP, Haupenthal VJ, Zimmer VC, Hartmann T (2013) Neprilysin and A\u03b2 clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer\u2019s disease. In: Frontiers in Aging Neuroscience. (Vol. 5, Issue DEC), Frontiers Media SA. https:\/\/doi.org\/10.3389\/fnagi.2013.00098","DOI":"10.3389\/fnagi.2013.00098"},{"key":"2873_CR33","doi-asserted-by":"publisher","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian ZS (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141(7):1917\u20131933.\u00a0https:\/\/doi.org\/10.1093\/brain\/awy132","DOI":"10.1093\/brain\/awy132"},{"key":"2873_CR34","doi-asserted-by":"publisher","unstructured":"Holthoff VA, Ferris S, Ihl R, Robert P, Winblad B, Gauthier S, Sternberg K, Tennigkeit F (2011) Validation of the relevant outcome scale for Alzheimer\u2019s disease: a novel multidomain assessment for daily medical practice. Alzheimer\u2019s Research and Therapy 3(5). https:\/\/doi.org\/10.1186\/alzrt89","DOI":"10.1186\/alzrt89"},{"key":"2873_CR35","unstructured":"Jafarlou M (2016). An overview of the history, applications, advantages, disadvantages and prospects of gene therapy. https:\/\/www.researchgate.net\/publication\/304988303"},{"key":"2873_CR36","unstructured":"Katal PS (n.d.). Human gene therapy"},{"issue":"1","key":"2873_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s40478-018-0640-z","volume":"6","author":"C Klein","year":"2018","unstructured":"Klein C, Roussel G, Brun S, Rusu C, Patte-Mensah C, Maitre M, Mensah-Nyagan AG (2018) 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer\u2019s disease. Acta Neuropatholog Commun 6(1):136. https:\/\/doi.org\/10.1186\/s40478-018-0640-z","journal-title":"Acta Neuropatholog Commun"},{"key":"2873_CR38","doi-asserted-by":"publisher","unstructured":"Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, Suehiro T, Mori K, Ikeda M, Fujita K et al (2021) Repurposing bromocriptine for A\u03b2 metabolism in Alzheimer\u2019s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer\u2019s disease with presenilin 1 (PSEN1) mutations. BMJ Open 11(6). https:\/\/doi.org\/10.1136\/bmjopen-2021-051343","DOI":"10.1136\/bmjopen-2021-051343"},{"key":"2873_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.12.001","volume-title":"Trends in Endocrinology and Metabolism. (Vol. 28, Issue 4, pp. 273\u2013284)","author":"C Lane-Donovan","year":"2017","unstructured":"Lane-Donovan C, Herz J (2017) ApoE, ApoE receptors, and the synapse in Alzheimer\u2019s disease. In: Trends in Endocrinology and Metabolism. (Vol. 28, Issue 4, pp. 273\u2013284). Elsevier Inc. https:\/\/doi.org\/10.1016\/j.tem.2016.12.001"},{"issue":"17","key":"2873_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21176336","volume":"21","author":"MF Lanfranco","year":"2020","unstructured":"Lanfranco MF, Ng CA, Rebeck GW (2020) ApoE lipidation as a therapeutic target in Alzheimer\u2019s disease. Int J Molecular Sci 21(17):1\u201319. https:\/\/doi.org\/10.3390\/ijms21176336","journal-title":"Int J Molecular Sci"},{"key":"2873_CR41","unstructured":"Lee E, Son H (n.d.). Adult hippocampal neurogenesis and related neurotrophic factors. http:\/\/bmbreports.org"},{"issue":"5","key":"2873_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5483\/BMBRep.2009.42.5.239","volume":"42","author":"E-G Lee","year":"2009","unstructured":"Lee E-G, Son H (2009) Adult hippocampal neurogenesis and related neurotrophic factors. BMB Reports 42(5):239\u2013244. https:\/\/doi.org\/10.5483\/BMBRep.2009.42.5.239","journal-title":"BMB Reports"},{"key":"2873_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.omtm.2019.12.012","volume":"17","author":"Y Li","year":"2020","unstructured":"Li Y, Wang Y, Wang J, Chong KY, Xu J, Liu Z, Shan C (2020) Expression of neprilysin in skeletal muscle by ultrasound-mediated gene transfer (sonoporation) reduces amyloid burden for AD. Mole Therapy - Meth Clin Develop 17:300\u2013308. https:\/\/doi.org\/10.1016\/j.omtm.2019.12.012","journal-title":"Mole Therapy - Meth Clin Develop"},{"key":"2873_CR44","doi-asserted-by":"publisher","unstructured":"Lim CS, Han JS (2018) The antioxidant xanthorrhizol prevents amyloid-\u03b2-induced oxidative modification and inactivation of neprilysin. Biosci Rep 38(1). https:\/\/doi.org\/10.1042\/BSR20171611","DOI":"10.1042\/BSR20171611"},{"key":"2873_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0063-8","volume-title":"Signal Transduction and Targeted Therapy (Vol. 4, Issue 1)","author":"PP Liu","year":"2019","unstructured":"Liu PP, Xie Y, Meng XY, Kang JS (2019) History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. In: Signal Transduction and Targeted Therapy (Vol. 4, Issue 1). Springer Nature. https:\/\/doi.org\/10.1038\/s41392-019-0063-8"},{"key":"2873_CR46","doi-asserted-by":"publisher","unstructured":"Loera\u2010Valencia R, Piras A, Ismail MAM, Manchanda S, Eyjolfsdottir H, Saido TC, Nilsson P (2018) Targeting alzheimer's disease with gene and cell therapies. J Intern Med 284(1):2\u201336.\u00a0https:\/\/doi.org\/10.1111\/joim.12759","DOI":"10.1111\/joim.12759"},{"key":"2873_CR47","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297916070063","volume-title":"Biochemistry (Moscow) (Vol. 81, Issue 7, pp. 700\u2013708)","author":"AN Lukashev","year":"2016","unstructured":"Lukashev AN, Zamyatnin AA (2016) Viral vectors for gene therapy: current state and clinical perspectives. In: Biochemistry (Moscow) (Vol. 81, Issue 7, pp. 700\u2013708). Maik Nauka Publishing \/ Springer SBM. https:\/\/doi.org\/10.1134\/S0006297916070063"},{"key":"2873_CR48","doi-asserted-by":"publisher","unstructured":"Marr R, Hafez D (2014) Amyloid beta and Alzheimer\u2019s disease: the role of neprilysin-2 in amyloid-beta clearance. Frontiers in Aging. Neuroscience 6(JUL). https:\/\/doi.org\/10.3389\/fnagi.2014.00187","DOI":"10.3389\/fnagi.2014.00187"},{"key":"2873_CR49","unstructured":"Mcconnell 1999 (n.d.)."},{"key":"2873_CR50","doi-asserted-by":"publisher","unstructured":"Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G (2016) Therapies for prevention and treatment of Alzheimer\u2019s disease.\u00a0Biomed Res Int 2016:1\u201317.\u00a0https:\/\/doi.org\/10.1155\/2016\/2589276","DOI":"10.1155\/2016\/2589276"},{"issue":"1","key":"2873_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/14636778.2019.1637718","volume":"39","author":"R Milne","year":"2020","unstructured":"Milne R (2020) The rare and the common: scale and the genetic imaginary in Alzheimer\u2019s disease drug development. New Genetics Soc 39(1):101\u2013126. https:\/\/doi.org\/10.1080\/14636778.2019.1637718","journal-title":"New Genetics Soc"},{"key":"2873_CR52","first-page":"127","volume":"61","author":"S Misra","year":"2013","unstructured":"Misra S (2013) Human gene therapy\u00a0: a brief overview of the genetic revolution. JAPI 61:127\u2013133","journal-title":"JAPI"},{"key":"2873_CR53","doi-asserted-by":"publisher","unstructured":"M\u00fccke MM, FongS, FosterGR, Lillicrap D, Miesbach W, Zeuzem S (2023). Adeno-associated viruses for gene therapy \u2013 clinical implications and liver related complications, a guide for hepatologists. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.029","DOI":"10.1016\/j.jhep.2023.10.029"},{"key":"2873_CR54","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1111\/bph.v176.18\/issuetoc","volume":"176","author":"NN Nalivaeva","year":"2019","unstructured":"Nalivaeva NN, Turner AJ (2019) Targeting amyloid clearance in Alzheimer\u2019s disease as a therapeutic strategy. Br J Pharmacol 176:3447\u20133463. https:\/\/doi.org\/10.1111\/bph.v176.18\/issuetoc","journal-title":"Br J Pharmacol"},{"key":"2873_CR55","doi-asserted-by":"publisher","unstructured":"Nalivaeva NN, Zhuravin IA, Turner AJ (2020). Neprilysin expression and functions in development, ageing and disease. Mechanisms of Ageing and Development, 192. https:\/\/doi.org\/10.1016\/j.mad.2020.111363","DOI":"10.1016\/j.mad.2020.111363"},{"key":"2873_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-017-0234-5","volume-title":"BioDrugs (Vol. 31, Issue 4, pp. 317\u2013334)","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL, Strohl WR (2017) Adeno-associated virus (AAV) as a vector for gene therapy. In: BioDrugs (Vol. 31, Issue 4, pp. 317\u2013334). Springer International Publishing. https:\/\/doi.org\/10.1007\/s40259-017-0234-5"},{"issue":"1","key":"2873_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2277-9175.98152","volume":"1","author":"N Nayerossadat","year":"2012","unstructured":"Nayerossadat N, Ali P, Maedeh T (2012) Viral and nonviral delivery systems for gene delivery. Advanced Biomedical Research 1(1):27. https:\/\/doi.org\/10.4103\/2277-9175.98152","journal-title":"Advanced Biomedical Research"},{"key":"2873_CR58","doi-asserted-by":"publisher","unstructured":"Nilsson P, Iwata N, Muramatsu SI, Tjernberg LO, Winblad B, Saido TC (2010) Gene therapy in Alzheimer\u2019s disease - potential for disease modification. J Cell Mole Med 14(4):741\u2013757. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01038.x","DOI":"10.1111\/j.1582-4934.2010.01038.x"},{"key":"2873_CR59","doi-asserted-by":"publisher","unstructured":"Numakawa T, Odaka H (2021). Brain-derived neurotrophic factor signaling in the pathophysiology of Alzheimer\u2019s disease: beneficial effects of flavonoids for neuroprotection. In: International Journal of Molecular Sciences (Vol. 22, Issue 11). MDPI. https:\/\/doi.org\/10.3390\/ijms22115719","DOI":"10.3390\/ijms22115719"},{"key":"2873_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)02076-7","volume-title":"FEBS Letters. (Vol. 483, Issue 1, pp. 6\u201310)","author":"J Nunan","year":"2000","unstructured":"Nunan J, Small DH (2000) Regulation of APP cleavage by \u03b1-, \u03b2- and \u03b3-secretases. In: FEBS Letters. (Vol. 483, Issue 1, pp. 6\u201310). Elsevier. https:\/\/doi.org\/10.1016\/S0014-5793(00)02076-7"},{"key":"2873_CR61","doi-asserted-by":"publisher","unstructured":"Paul A, Collins MG, Lee HY (2022) Gene therapy: the next-generation therapeutics and their delivery approaches for neurological disorders. In: Frontiers in Genome Editing (Vol. 4), Frontiers Media S.A. https:\/\/doi.org\/10.3389\/fgeed.2022.899209","DOI":"10.3389\/fgeed.2022.899209"},{"key":"2873_CR62","doi-asserted-by":"publisher","unstructured":"Reitz C (2015). Genetic diagnosis and prognosis of Alzheimer\u2019s disease: challenges and opportunities. In: Expert Review of Molecular Diagnostics (Vol. 15, Issue 3, pp. 339\u2013348). Expert Reviews Ltd. https:\/\/doi.org\/10.1586\/14737159.2015.1002469","DOI":"10.1586\/14737159.2015.1002469"},{"key":"2873_CR63","doi-asserted-by":"publisher","unstructured":"Robinson M, Lee BY, Hane FT (2017). Recent progress in Alzheimer\u2019s disease research, part 2: genetics and epidemiology. In: Journal of Alzheimer\u2019s disease\u00a0: JAD (Vol. 57, Issue 2, pp. 317\u2013330). https:\/\/doi.org\/10.3233\/JAD-161149","DOI":"10.3233\/JAD-161149"},{"issue":"2","key":"2873_CR64","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/thno.50263","volume":"11","author":"F Rofo","year":"2020","unstructured":"Rofo F, Yilmaz CU, Metzendorf N, Gustavsson T, Beretta C, Erlandsson A, Sehlin D, Syv\u00e4nen S, Nilsson P, Hultqvist G (2020) Enhanced neprilysin-mediated degradation of hippocampal A\u03b242 with a somatostatin peptide that enters the brain. Theranostics 11(2):789\u2013804. https:\/\/doi.org\/10.7150\/thno.50263","journal-title":"Theranostics"},{"issue":"7","key":"2873_CR65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/1348-0421.12602","volume":"62","author":"M Sakai","year":"2018","unstructured":"Sakai M, Ueda S, Daito T, Asada-Utsugi M, Komatsu Y, Kinoshita A, Maki T, Kuzuya A, Takahashi R, Makino A, Tomonaga K (2018) Degradation of amyloid \u03b2 peptide by neprilysin expressed from Borna disease virus vector. Microbiol Immun 62(7):467\u2013472. https:\/\/doi.org\/10.1111\/1348-0421.12602","journal-title":"Microbiol Immun"},{"key":"2873_CR66","doi-asserted-by":"publisher","unstructured":"Scheltens P, de Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. In: The Lancet (Vol. 397, Issue 10284, pp. 1577\u20131590), Elsevier B.V. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"2873_CR67","doi-asserted-by":"publisher","unstructured":"Selkirk SM (2004). Gene therapy in clinical medicine. In: Postgraduate Medical Journal (Vol. 80, Issue 948, pp. 560\u2013570). https:\/\/doi.org\/10.1136\/pgmj.2003.017764","DOI":"10.1136\/pgmj.2003.017764"},{"key":"2873_CR68","doi-asserted-by":"publisher","unstructured":"Sharma S, Behl T, Kumar A, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harrasi A, Bungau S (2021) Targeting endothelin in Alzheimer\u2019s disease: a promising therapeutic approach. In: BioMed Research International (Vol. 2021), Hindawi Limited. https:\/\/doi.org\/10.1155\/2021\/7396580","DOI":"10.1155\/2021\/7396580"},{"issue":"9","key":"2873_CR69","doi-asserted-by":"publisher","first-page":"868","DOI":"10.2174\/1570159x18666200128121920","volume":"18","author":"RK Singh","year":"2020","unstructured":"Singh RK (2020) Recent trends in the management of Alzheimer\u2019s disease: current therapeutic options and drug repurposing approaches. Curr Neuropharmacol 18(9):868\u2013882. https:\/\/doi.org\/10.2174\/1570159x18666200128121920","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"2873_CR70","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1534\/genetics.113.160945","volume":"196","author":"JL Sitnik","year":"2014","unstructured":"Sitnik JL, Francis C, Hens K, Huybrechts R, Wolfner MF, Callaerts P (2014) Neprilysins: an evolutionarily conserved family of metalloproteases that play important roles in reproduction in Drosophila. Genetics 196(3):781\u2013797. https:\/\/doi.org\/10.1534\/genetics.113.160945","journal-title":"Genetics"},{"key":"2873_CR71","doi-asserted-by":"publisher","DOI":"10.4103\/picr.PICR_189_20","volume-title":"Perspectives in Clinical Research (Vol. 12, Issue 3, pp. 118\u2013125)","author":"K Sivagourounadin","year":"2021","unstructured":"Sivagourounadin K, Ravichandran M, Rajendran P (2021) National guidelines for gene therapy product (2019): a road-map to gene therapy products development and clinical trials. In: Perspectives in Clinical Research (Vol. 12, Issue 3, pp. 118\u2013125). Wolters Kluwer Medknow Publications. https:\/\/doi.org\/10.4103\/picr.PICR_189_20"},{"issue":"2","key":"2873_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/diseases6020042","volume":"103","author":"N Slade","year":"2001","unstructured":"Slade N (2001) Viral vectors in gene therapy. Periodicum Biologorum 103(2):139\u2013143. https:\/\/doi.org\/10.3390\/diseases6020042","journal-title":"Periodicum Biologorum"},{"issue":"3","key":"2873_CR73","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.scr.2014.10.001","volume":"13","author":"K Takamatsu","year":"2014","unstructured":"Takamatsu K, Ikeda T, Haruta M, Matsumura K, Ogi Y, Nakagata N, Uchino M, Ando Y, Nishimura Y, Senju S (2014) Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Research 13(3):442\u2013453. https:\/\/doi.org\/10.1016\/j.scr.2014.10.001","journal-title":"Stem Cell Research"},{"key":"2873_CR74","doi-asserted-by":"publisher","unstructured":"Trapani I (2019) Adeno-associated viral vectors as a tool for large gene delivery to the retina. Genes 10(4). https:\/\/doi.org\/10.3390\/genes10040287","DOI":"10.3390\/genes10040287"},{"issue":"10","key":"2873_CR75","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","volume":"72","author":"MH Tuszynski","year":"2015","unstructured":"Tuszynski MH, Yang JH, Barba D, Hoi-Sang U, Bakay RAE, Pay MM, Masliah E, Conner JM, Kobalka P, Roy S, Nagahara AH (2015) Nerve growth factor gene therapy activation of neuronal responses in Alzheimer disease. JAMA Neurology 72(10):1139\u20131147. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1807","journal-title":"JAMA Neurology"},{"issue":"2","key":"2873_CR76","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","volume":"60","author":"W Walther","year":"2000","unstructured":"Walther W, Stein U (2000) Viral vectors for gene transfer. Drugs 60(2):249\u2013271. https:\/\/doi.org\/10.2165\/00003495-200060020-00002","journal-title":"Drugs"},{"key":"2873_CR77","doi-asserted-by":"publisher","unstructured":"Wierenga CE, Hays CC, Zlatar ZZ (2014). Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer\u2019s disease. In Journal of Alzheimer\u2019s Disease (Vol. 42, pp. S411\u2013S419). IOS Press. https:\/\/doi.org\/10.3233\/JAD-141467","DOI":"10.3233\/JAD-141467"},{"key":"2873_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.12.008","volume-title":"Biochemical Pharmacology (Vol. 88, Issue 4, pp. 529\u2013539)","author":"CM Wischik","year":"2014","unstructured":"Wischik CM, Harrington CR, Storey JMD (2014) Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease. In: Biochemical Pharmacology (Vol. 88, Issue 4, pp. 529\u2013539). Elsevier Inc. https:\/\/doi.org\/10.1016\/j.bcp.2013.12.008"},{"key":"2873_CR79","doi-asserted-by":"publisher","unstructured":"Wong KH, Riaz MK, Xie Y, Zhang X, Liu Q, Chen H, Bian Z, Chen X, Lu A, Yang Z (2019). Review of current strategies for delivering Alzheimer\u2019s disease drugs across the blood-brain barrier. In: International Journal of Molecular Sciences (Vol. 20, Issue 2). MDPI AG. https:\/\/doi.org\/10.3390\/ijms20020381","DOI":"10.3390\/ijms20020381"},{"key":"2873_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1402-1","volume-title":"Journal of Translational Medicine (Vol. 16, Issue 1)","author":"P Wu","year":"2018","unstructured":"Wu P, Chen H, Jin R, Weng T, Ho JK, You C, Zhang L, Wang X, Han C (2018) Non-viral gene delivery systems for tissue repair and regeneration. In: Journal of Translational Medicine (Vol. 16, Issue 1). BioMed Central Ltd. https:\/\/doi.org\/10.1186\/s12967-018-1402-1"},{"key":"2873_CR81","doi-asserted-by":"publisher","unstructured":"Xiao Q, Guo D, Chen S (2019) Application of CRISPR\/Cas9-based gene editing in HIV-1\/AIDS therapy. In: Frontiers in Cellular and Infection Microbiology (Vol. 9, Issue MAR), Frontiers Media S.A. https:\/\/doi.org\/10.3389\/fcimb.2019.00069","DOI":"10.3389\/fcimb.2019.00069"},{"key":"2873_CR82","doi-asserted-by":"publisher","unstructured":"Yang A, Kantor B, Chiba-Falek O (2021). Apoe: the new frontier in the development of a therapeutic target towards precision medicine in late-onset alzheimer\u2019s. In: International Journal of Molecular Sciences (Vol. 22, Issue 3, pp. 1\u201315). MDPI AG. https:\/\/doi.org\/10.3390\/ijms22031244","DOI":"10.3390\/ijms22031244"},{"key":"2873_CR83","doi-asserted-by":"publisher","unstructured":"Yiannopoulou KG, Papageorgiou SG (2013) Current and future treatments for Alzheimer\u2019s disease. Therapeutic advances in neurological disorders 6(1):19\u201333.\u00a0https:\/\/doi.org\/10.1177\/1756285612461679","DOI":"10.1177\/1756285612461679"},{"issue":"1","key":"2873_CR84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1515\/tnsci-2020-0178","volume":"12","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Li Y, Shen H, Lin N, Zhang J (2021) Tripchlorolide attenuates \u03b2-amyloid generation by inducing NEP activity in N2a\/APP695 cells. Translational Neuroscience 12(1):301\u2013308. https:\/\/doi.org\/10.1515\/tnsci-2020-0178","journal-title":"Translational Neuroscience"},{"key":"2873_CR85","doi-asserted-by":"publisher","unstructured":"Zhao N, Liu CC, Qiao W, Bu G (2018) Apolipoprotein E, receptors, and modulation of Alzheimer\u2019s disease. In: Biological Psychiatry (Vol. 83, Issue 4, pp. 347\u2013357), Elsevier USA. https:\/\/doi.org\/10.1016\/j.biopsych.2017.03.003","DOI":"10.1016\/j.biopsych.2017.03.003"},{"key":"2873_CR86","unstructured":"Zhou L, Liu J, Dong D, Wei C, Wang R (2017). Dynamic alteration of neprilysin and endothelin-converting enzyme in age-dependent APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. In: Am J Transl Res (Vol. 9, Issue 1). www.ajtr.org"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02873-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02873-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02873-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T08:16:47Z","timestamp":1716365807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02873-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2873"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02873-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"11 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval is needed. No animal study performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}